NeoCore Technology Co., Ltd.

NT$30.55As of Sun 8 Nov 2026, 12:00 UTC
TPEx:4131Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 5.93%
Div yield —
ROE (10.63%)
Biotechnology
Beta (5Y) (0.24)
PE TTM —
TSR TTM (3.48%)
Mkt cap NT$1.218B
ROIC (4.05%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$32
4.73%
(96.41%)
Hold 11|6|5|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.38
0.43
0.45
0.46
9.39%
18.15%
18.15%
24.22%
RevenueNT$M
69.34
67.90
67.46
67.45
8.47%
0.35%
(1.86%)
(5.30%)
Peers (US$36.78M)
Cap (US$)
PE
37.25M
—
Capital
TTM
5Y
10Y
Leveragex
1.899
1.178
0.911
EBIT/Intx
0.643
0.383
0.330
Own earn%
93.27
(24.75)
(36.91)
Sh yield%
49.99
50.63
50.07
Owners
Insiders/Inst%
6.37
58.33
Short interest%
2.07
SBC / revenue%
5.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
3–8
$1 testx
0.1
Incr. ROIC%
7